MORE DETAILS ON OUR COVID MEASURES - CLICK THIS BAR
Leiomyosarcoma is a common form of soft tissue sarcoma. Leiomyosarcoma arise from smooth muscle. Smooth muscle is found within hollow organs of the body, including the bladder, bowel and blood vessels. In females, there is smooth muscle seen within the uterus.
Leiomyosarcoma most often develops in adults between the age of 40 and 70 years.
Leiomyosarcoma development is still poorly understood. It results due to DNA mutations in smooth muscle cells leading to uncontrolled growth and formation of mutated cells, resulting in tumour formation.
Leiomyosarcoma causes are not completely understood. Some genetic conditions are associated with leiomyosarcoma development and these include:
The symptoms for Leiomyosarcoma include:
Doctors use a variety of tests to confirm a leiomyosarcoma diagnosis. These tests include the following:
The most common treatment for leiomyosarcoma is surgical removal of the tumour. This can be a challenging process, especially if the tumour involves a major vessel, as this requires reconstruction of the vessel after the tumour has been removed.
The aim of surgery is to remove the tumour with a margin of normal surrounding tissue if possible. This improves the chance of cure and reduces the risk of the tumour re-occurring.
Sometimes, radiation therapy or chemotherapy is given before surgery to help shrink the tumour.
The use of radiotherapy for these tumours is common. Radiotherapy (either before or after surgery) is useful in the management of leiomyosarcomas. It has been shown to reduce the chance of the tumour re-occurring locally after surgical resection.
Chemotherapy is reserved for select cases, as studies have shown little benefit from chemotherapy following surgical resection of leiomyosarcoma.
Contact Details
Suite 1A, Level 7, Prince of Wales Private Hospital, Randwick, 2031
(02) 8073 9462